Iran expects first batch of Russian vaccine by Feb 4

Credit: CC0 Public Domain

Iran’s ambassador to Russia said Saturday that Tehran expects to receive the first batch of Moscow’s Sputnik V coronavirus vaccine by February 4, state news agency IRNA reported.

The news comes just days after Iran’s Foreign Minister Mohammad Javad Zarif announced the vaccine had been approved by the Islamic republic.

“A contract for the purchase and joint production was signed yesterday between Iran and Russia,” envoy Kazem Jalali said, quoted by IRNA.

Two more batches are to be delivered by February 18 and 28, he added, without specifying quantities.

Iran’s supreme leader Ayatollah Ali Khamenei earlier this month banned the use of vaccines made by the United States and Britain, calling them “completely untrustworthy”.

Read:US virus deaths surpass 450K; daily toll is stubbornly high

Iran is fighting the Middle East’s deadliest outbreak of COVID-19 with more than 57,800 dead out of over 1.4 million cases.

The country says arch enemy US has blocked its access to vaccines through Washington’s tough sanctions regime.

While food and medicine are technically exempt, international banks tend to refuse transactions involving Iran.

Russia registered the jab—named after the Soviet-era satellite—in August last year, before the start of large-scale clinical trials, leaving some experts wary.

Sputnik V’s developers have since said the vaccine is more than 90 percent effective and several countries outside of Russia have begun administering it, including Argentina.

Hungary has also said it has reached a deal to buy the vaccine, although it has not been approved by the European Union.

Iran started clinical trials of its own vaccine in late December.

Read:HCQ has no significant impact on heart rhythm in lupus patients, even those with CKD

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2021 AFP

Read:Nearly one in four families hesitant to take their child to ER during COVID-19 pandemic

Iran expects first batch of Russian vaccine by Feb 4 (2021, January 30)
retrieved 30 January 2021

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Previous post
Nivolumab effective treatment for malignant mesothelioma
Next post
Selected gene mRNA expression is not predictive of improved overall survival